Learn more

ORTHO PHARMA CORP

Overview
  • Total Patents
    3,150
About

ORTHO PHARMA CORP has a total of 3,150 patent applications. Its first patent ever was published in 1944. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INST ORGANICHESKOGO SINTEZA AK, STYLED SANOFI SA and SPOFA SPOJENE POD PRO ZDRAVOTN.

Patent filings per year

Chart showing ORTHO PHARMA CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Goldstein Gideon 234
#2 Bandurco Victor T 111
#3 Heavner George 102
#4 Kung Patrick Chung-Shu 93
#5 Press Jeffery B 86
#6 Tobia Alfonso J 85
#7 Kanojia Ramesh M 77
#8 Falotico Robert 72
#9 Schwender Charles F 72
#10 Press Jeffrey B 71

Latest patents

Publication Filing date Title
KR100257643B1 Polyethylene glycol hydrazone, polyethylene glycol oxime linkage forming reagents and protein derivatives thereof
AU1425499A Multilayered controlled release pharmaceutical dosage form
US5994563A Arylmethylphosphonic acid derivatives useful in treating bone wasting diseases
US6136559A DNA encoding as human histamine receptor of the H3 subtype
US5925769A Acetylenic 1,5-diarylpyrazoles as antiinflammatory agents
WO9909993A1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
US6251956B1 Combination progestin oral contraceptive regimen
US6039208A Variable day start tablet dispenser
WO9824814A2 N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions
US5843958A Arylpyrazoles as leukotriene inhibitors
CN1236435A A dissolution test method for solid steroidal pharmaceutical formulations
WO9817636A1 Phenylalaninol derivatives for the treatment of central nervous system disorders
US5908754A Method for in vitro determination of in vivo erythropoeitin bioactivity
ZA9708934B 5-Heteroatom-containing alkyl substituted-3-oxo-pyrido(1,2-a) benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
WO9815553A1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
US5942532A 2-substituted phenyl-benzimidazole antibacterial agents
WO9815270A1 Anticonvulsant derivatives useful in treating neuropathic pain
US5760007A Anticonvulsant derivatives useful in treating neuropathic pain
US5833072A Dosage regimen container
US5922731A 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders